Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 48.97
+3.46 (7.60%)
At close: Mar 6, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 6.37 billion as of March 6, 2026. Its market cap has increased by 44.55% in one year.
Market Cap
6.37B
Enterprise Value
5.05B
Revenue
354.91M
Ranking
n/a
PE Ratio
132.35
Stock Price
48.97
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 6.37B, a decrease of -38.95%. That is a compound annual growth rate of -13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.37B | 14.18% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Aidea Pharmaceutical Group | 6.93B |
| Shenzhen Weiguang Biological Products | 6.57B |
| Lifecome Biochemistry | 6.54B |
| Beijing Konruns Pharmaceutical | 6.50B |
| R&G PharmaStudies | 6.30B |
| Xiangxue Pharmaceutical | 6.22B |
| GemPharmatech | 6.05B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.86B |